MAP2K7 and neoplasm: Based on the above in vivo data suggesting that MEK inhibition potentially reduces the number and activation status of T-cells within the MOC tumor microenvironment, we experimentally measured the effect of MEK and mTOR inhibition on T-cells in vitro.